Skip to main content

CAPITAL FUND MANAGEMENT S.A.

Position in ROIV — Roivant Sciences Ltd.

CIK 1323645 PARIS, I0

Position in ROIV

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$678,532
+$199,406 QoQ
Shares Held
19,173
+10.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#257
of 494 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ROIV Over Time

Shares Held

Position Value (USD)

Derivatives in ROIV

reported options exposure · as of Mar 31, 2026
CallValue
$481,980
CallShares
17,400
PutValue
$346,250
PutShares
12,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CAPITAL FUND MANAGEMENT S.A. holds $326,278,392 across 42 Biotechnology names. ROIV ranks #37 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ROIV

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $678,532 19,173
2026-03-31 $346,250 12,500
2026-03-31 $481,980 17,400
2026-03-31 $479,126 17,297
2025-12-31 $685,720 31,600
2025-12-31 $494,760 22,800
2025-09-30 $443,309 29,300